Bruce Keyt - 15 Nov 2021 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role
Chief Scientific Officer
Signature
/s/ Misbah Tahir, by power of attorney
Issuer symbol
IGMS
Transactions as of
15 Nov 2021
Net transactions value
+$7,088
Form type
4
Filing time
17 Nov 2021, 17:48:41 UTC
Previous filing
03 Nov 2021
Next filing
15 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IGMS Common Stock Award $7,088 +139 +4.5% $50.99* 3,196 15 Nov 2021 Direct F1
holding IGMS Common Stock 1,013 15 Nov 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired under the IGM Biosciences, Inc. 2019 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
F2 The shares are held directly by the reporting person's spouse.